Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report

Autor: Fabio Salimei, Antonio Orlacchio, Ilaria Lenci, Fulvio Gasparrini, Maria Giulia Gagliardi, Marco Spada
Jazyk: angličtina
Rok vydání: 2021
Předmět:
medicine.medical_specialty
congenital
hereditary
and neonatal diseases and abnormalities
Heart disease
TACE
trans-arterial-chemoembolization
R895-920
SMA
Superior Mesenteric Artery
Case Report
CM
Contrast Medium
IVC-PA
Inferior Vena Cava-Pulmonary Artery
Chronic liver disease
MRI
Magnetic Resonance Imaging
ceCT
Contrast Enhanced CT
Medical physics. Medical radiology. Nuclear medicine
Fontan surgery
CT
Computed Tomography
EDVi
End- Diastolic Volume index
EF
Ejection Fraction
Settore MED/36
medicine
Radiology
Nuclear Medicine and imaging
Liver neoplasm
SI
Situs inversus
FALD
Fontan-associated liver disease
bpm
beats per minute
Cardiac cirrhosis
Congenital heart disease
TACE
Trans Arterial ChemoEmbolization
business.industry
HR
Heart Rate
Ultrasound
ceCT
contrast enhanced Computed Tomography
medicine.disease
Surgery
Transplantation
US
Ultrasound
medicine.anatomical_structure
Ventricle
Hepatocellular carcinoma
Liver function
Situs viscerum inversus
business
HCC
hepatocellular carcinoma
Zdroj: Radiology Case Reports
Radiology Case Reports, Vol 16, Iss 9, Pp 2564-2569 (2021)
ISSN: 1930-0433
Popis: We describe the case of a 32-year-old man who developed a liver neoplasm due to previous Fontan surgery (FS) for a single ventricle anomaly and situs viscerum inversus. He was admitted to our hospital for suspected hepatocellular carcinoma during an Ultrasound (US) follow up. Computed tomography (CT) showed features of chronic liver disease and 7 cm hepatic nodule with arterial enhancement. Laboratory analyses documented preserved liver function and increased levels of alpha-fetoprotein. Trans-arterial-chemoembolization (TACE) was performed obtaining complete necrosis at 4 weeks of follow up and significant reduction of alpha-fetoprotein. The patient is currently in follow-up, being evaluated for further treatments and/or combined liver-heart transplantation. TACE is a therapeutic option for the treatment of patients with unresectable hepatocellular carcinoma (HCC) and with severe heart disease, like those submitted to FS and with also other vascular abnormalities like those correlated to situs viscerum inversus.
Databáze: OpenAIRE
Externí odkaz: